RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States.
$76.00-2.58%
报价 2026-11-06
市值
$5.98B
EV
$7.44B
PE (TTM)
–
预期 PE (FY2026)
147.8x
52 周区间距高点 -10.0%
$51.87$84.48
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.2x | 0.44 → 0.90（2.0x） | 84.9 |
| FY+32028-12 | 1.4x | 0.44 → 1.11（2.5x） | 68.5 |
毛利率 10% · TTM 收入 $2269M · 基数 EPS 0.44（调整后）
研究结论
L2 2026-07-06全文 ↓尚未生成 L3 估值，没有三情景目标价。去生成估值 →
L2 报告格式无法提取要点，请看全文。
历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| RDNTRadNet, Inc. | $5.98B | -2.6% | +24.9% | 14.1% | – | 26.8x | – | |
| BTSGBrightSpring Health Services, Inc. Common Stock | $13.36B | +2.0% | +25.7% | 12.3% | 40.9x | 21.2x | 27.1x | |
| BRKRBruker Corporation | $9.34B | +5.6% | +3.9% | 49.1% | – | 88.8x | 38.2x | |
| KRYSKrystal Biotech, Inc. | $8.92B | +0.2% | +34.7% | 92.6% | 35.3x | 40.7x | 46.7x | |
| BLCOBausch + Lomb Corporation | $7.15B | +0.4% | +8.2% | 60.5% | – | 17.1x | 28.2x | |
| CHEChemed Corporation | $6.87B | -1.1% | +5.6% | 31.1% | 19.7x | 12.6x | 20.9x | |
| TFXTeleflex Incorporated | $6.39B | -0.8% | -30.7% | 53.3% | – | 63.6x | 26.1x | |
| MMSIMerit Medical Systems, Inc. | $5.23B | -2.7% | +7.1% | 48.7% | 31.5x | 13.5x | 20.7x | |
| SHCSotera Health Company | $4.57B | +0.9% | +7.3% | 55.4% | 34.1x | 13.9x | 49.5x | |
| 同行中位数 | – | – | +7.2% | 51.2% | 34.1x | 19.1x | 27.6x |
研究全文
财务报表
| Metric | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 | 2024-09-30 Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $622.7M | $575.6M | $547.7M | $522.9M | $498.2M | $471.4M | $477.1M | $461.1M |
| Gross Margin | 14.1% | -2.8% | 13.9% | 13.9% | 13.9% | 3.8% | 13.8% | 15% |
| Operating Margin | 6.3% | -2.8% | 6.4% | 6.3% | 6.2% | -5.1% | 5.1% | 7.4% |
| Net Income | $7.5M | $-33.5M | $-597,000 | $5.4M | $14.5M | $-37.9M | $5.3M | $3.2M |
| Diluted EPS | 0.1 | -0.43 | -0.01 | 0.07 | 0.19 | -0.51 | 0.07 | 0.04 |
| Operating Cash Flow | $87.8M | $92.3M | $84.2M | $52.8M | $120.3M | $41.5M | $42.5M | $57.4M |